Rare diseases
Investigational molecules
Locations
379 conditions with trials, the busiest first
1 276 trials across Europe, recruiting first
Study of Atezolizumab and Chemotherapy for Patients with Non-Resectable Non-Small Cell Lung Cancer
SpainStudy on Preserving the Voice Box in Patients with Advanced Laryngeal or Hypopharyngeal Cancer Using Cisplatin, Fluorouracil, and Docetaxel Therapy
FranceStudy of BAT3306 or pembrolizumab with chemotherapy (carboplatin and pemetrexed) in patients with stage IV non-squamous non-small cell lung cancer
SlovakiaStudy on the Effects of Defosbarasertib and Durvalumab for Patients with Extensive-Stage Small Cell Lung Cancer
SpainStudy on the Effectiveness and Safety of OM-85 for Children Aged 6 Months to 5 Years with Recurrent Wheezing
HungaryStudy on Selpercatinib for Adults with Advanced or Metastatic Solid Tumors with RET Activation
FranceStudy of Sacituzumab Govitecan, Pembrolizumab, and a Platinum Drug Combination for Advanced Non-Small Cell Lung Cancer Patients Without Genomic Alterations
FranceStudy of INCB099280 for Patients with Advanced Solid Tumors Who Have Not Received Immunotherapy
GreeceStudy on the Safety and Effectiveness of Furmonertinib vs. Platinum-Based Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer
FranceStudy of MK-7684A with Chemoradiotherapy Compared to Chemoradiotherapy with Durvalumab for Patients with Stage III Non-Small Cell Lung Cancer
AustriaStudy on Aspirin and Pantoprazole for Reducing Heart Attack Risk in Hospitalized Pneumonia Patients
The NetherlandsStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol on Exercise in Patients with Chronic Obstructive Pulmonary Disease (COPD)
GermanyThe therapies tested most often in Respiratory, thoracic and mediastinal disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
